UniProt ID | EHMT2_MOUSE | |
---|---|---|
UniProt AC | Q9Z148 | |
Protein Name | Histone-lysine N-methyltransferase EHMT2 | |
Gene Name | Ehmt2 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 1263 | |
Subcellular Localization | Nucleus. Chromosome . Almost excluded form nucleoli. Associates with euchromatic regions. Does not associate with heterochromatin. Part of a complex composed of TRIM28, HDAC1, HDAC2 and EHMT2 (By similarity). Interacts with CDYL. Interacts with REST | |
Protein Description | Histone methyltransferase that specifically mono- and dimethylates 'Lys-9' of histone H3 (H3K9me1 and H3K9me2, respectively) in euchromatin. H3K9me represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones. Also mediates monomethylation of 'Lys-56' of histone H3 (H3K56me1) in G1 phase, leading to promote interaction between histone H3 and PCNA and regulating DNA replication. Also weakly methylates 'Lys-27' of histone H3 (H3K27me). Also required for DNA methylation, the histone methyltransferase activity is not required for DNA methylation, suggesting that these 2 activities function independently. Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1. May also methylate histone H1. In addition to the histone methyltransferase activity, also methylates non-histone proteins: mediates dimethylation of 'Lys-373' of p53/TP53. Also methylates CDYL, WIZ, ACIN1, DNMT1, HDAC1, ERCC6, KLF12 and itself.. | |
Protein Sequence | MRGLPRGRGLMRARGRGRAAPTGGRGRGRGGAHRGRGRPRSLLSLPRAQASWAPQLPAGLTGPPVPCLPSQGEAPAEMGALLLEKEPRGAAERVHSSLGDTPQSEETLPKANPDSLEPAGPSSPASVTVTVGDEGADTPVGAASLIGDEPESLEGDGGRIVLGHATKSFPSSPSKGGACPSRAKMSMTGAGKSPPSVQSLAMRLLSMPGAQGAATAGPEPSPATTAAQEGQPKVHRARKTMSKPSNGQPPIPEKRPPEVQHFRMSDDMHLGKVTSDVAKRRKLNSGSLSEDLGSAGGSGDIILEKGEPRPLEEWETVVGDDFSLYYDAYSVDERVDSDSKSEVEALAEQLSEEEEEEEEEEEEEEEEEEEEEEEEEDEESGNQSDRSGSSGRRKAKKKWRKDSPWVKPSRKRRKREPPRAKEPRGVNGVGSSGPSEYMEVPLGSLELPSEGTLSPNHAGVSNDTSSLETERGFEELPLCSCRMEAPKIDRISERAGHKCMATESVDGELLGCNAAILKRETMRPSSRVALMVLCEAHRARMVKHHCCPGCGYFCTAGTFLECHPDFRVAHRFHKACVSQLNGMVFCPHCGEDASEAQEVTIPRGDGGTPPIGTAAPALPPLAHDAPGRADTSQPSARMRGHGEPRRPPCDPLADTIDSSGPSLTLPNGGCLSAVGLPPGPGREALEKALVIQESERRKKLRFHPRQLYLSVKQGELQKVILMLLDNLDPNFQSDQQSKRTPLHAAAQKGSVEICHVLLQAGANINAVDKQQRTPLMEAVVNNHLEVARYMVQLGGCVYSKEEDGSTCLHHAAKIGNLEMVSLLLSTGQVDVNAQDSGGWTPIIWAAEHKHIDVIRMLLTRGADVTLTDNEENICLHWASFTGSAAIAEVLLNAQCDLHAVNYHGDTPLHIAARESYHDCVLLFLSRGANPELRNKEGDTAWDLTPERSDVWFALQLNRKLRLGVGNRAVRTEKIICRDVARGYENVPIPCVNGVDGEPCPEDYKYISENCETSTMNIDRNITHLQHCTCVDDCSSSNCLCGQLSIRCWYDKDGRLLQEFNKIEPPLIFECNQACSCWRSCKNRVVQSGIKVRLQLYRTAKMGWGVRALQTIPQGTFICEYVGELISDAEADVREDDSYLFDLDNKDGEVYCIDARYYGNISRFINHLCDPNIIPVRVFMLHQDLRFPRIAFFSSRDIRTGEELGFDYGDRFWDIKSKYFTCQCGSEKCKHSAEAIALEQSRLARLDPHPELLPDLSSLPPINT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
40 | Asymmetric dimethylarginine | HRGRGRPRSLLSLPR CCCCCCCCCHHCCCH | 38.28 | - | |
40 | Methylation | HRGRGRPRSLLSLPR CCCCCCCCCHHCCCH | 38.28 | 24129315 | |
41 | Phosphorylation | RGRGRPRSLLSLPRA CCCCCCCCHHCCCHH | 36.02 | 21743459 | |
44 | Phosphorylation | GRPRSLLSLPRAQAS CCCCCHHCCCHHHHC | 41.44 | 21743459 | |
96 | Phosphorylation | GAAERVHSSLGDTPQ CHHHHHHHHCCCCCC | 25.13 | 26824392 | |
97 | Phosphorylation | AAERVHSSLGDTPQS HHHHHHHHCCCCCCC | 22.84 | 28066266 | |
101 | Phosphorylation | VHSSLGDTPQSEETL HHHHCCCCCCCCCCC | 22.79 | 26643407 | |
104 | Phosphorylation | SLGDTPQSEETLPKA HCCCCCCCCCCCCCC | 38.31 | 26643407 | |
107 | Phosphorylation | DTPQSEETLPKANPD CCCCCCCCCCCCCCC | 44.29 | 28066266 | |
115 | Phosphorylation | LPKANPDSLEPAGPS CCCCCCCCCCCCCCC | 35.57 | 23649490 | |
122 | Phosphorylation | SLEPAGPSSPASVTV CCCCCCCCCCCEEEE | 48.30 | 22006019 | |
123 | Phosphorylation | LEPAGPSSPASVTVT CCCCCCCCCCEEEEE | 27.84 | 27087446 | |
126 | Phosphorylation | AGPSSPASVTVTVGD CCCCCCCEEEEEECC | 23.00 | 21659605 | |
128 | Phosphorylation | PSSPASVTVTVGDEG CCCCCEEEEEECCCC | 14.15 | 25293948 | |
130 | Phosphorylation | SPASVTVTVGDEGAD CCCEEEEEECCCCCC | 14.92 | 25293948 | |
138 | Phosphorylation | VGDEGADTPVGAASL ECCCCCCCCCCEEHH | 21.24 | 25293948 | |
144 | Phosphorylation | DTPVGAASLIGDEPE CCCCCEEHHHCCCCC | 21.71 | 24453211 | |
167 | "N6,N6-dimethyllysine" | IVLGHATKSFPSSPS EEEEEEECCCCCCCC | 51.38 | - | |
167 | Methylation | IVLGHATKSFPSSPS EEEEEEECCCCCCCC | 51.38 | - | |
171 | Phosphorylation | HATKSFPSSPSKGGA EEECCCCCCCCCCCC | 53.52 | 30635358 | |
172 | Phosphorylation | ATKSFPSSPSKGGAC EECCCCCCCCCCCCC | 33.17 | 26745281 | |
174 | Phosphorylation | KSFPSSPSKGGACPS CCCCCCCCCCCCCCC | 45.97 | 30635358 | |
186 | Phosphorylation | CPSRAKMSMTGAGKS CCCCCCCCCCCCCCC | 16.70 | 25159016 | |
188 | Phosphorylation | SRAKMSMTGAGKSPP CCCCCCCCCCCCCCH | 19.30 | 25159016 | |
193 | Phosphorylation | SMTGAGKSPPSVQSL CCCCCCCCCHHHHHH | 40.92 | 26824392 | |
196 | Phosphorylation | GAGKSPPSVQSLAMR CCCCCCHHHHHHHHH | 35.85 | 21659605 | |
199 | Phosphorylation | KSPPSVQSLAMRLLS CCCHHHHHHHHHHHC | 18.88 | 26643407 | |
221 | Phosphorylation | ATAGPEPSPATTAAQ CCCCCCCCCCCHHHH | 26.04 | 29514104 | |
239 | "N6,N6,N6-trimethyllysine" | PKVHRARKTMSKPSN CCCCCCCCCCCCCCC | 47.82 | - | |
239 | Methylation | PKVHRARKTMSKPSN CCCCCCCCCCCCCCC | 47.82 | - | |
285 | Phosphorylation | AKRRKLNSGSLSEDL HHHCCCCCCCCCCCH | 39.95 | 27087446 | |
287 | Phosphorylation | RRKLNSGSLSEDLGS HCCCCCCCCCCCHHC | 28.66 | 27087446 | |
289 | Phosphorylation | KLNSGSLSEDLGSAG CCCCCCCCCCHHCCC | 30.66 | 22942356 | |
294 | Phosphorylation | SLSEDLGSAGGSGDI CCCCCHHCCCCCCCE | 30.91 | 19060867 | |
298 | Phosphorylation | DLGSAGGSGDIILEK CHHCCCCCCCEEEEC | 32.16 | 21183079 | |
374 (in isoform 2) | Phosphorylation | - | 70.71 | 29514104 | |
375 (in isoform 2) | Phosphorylation | - | 74.22 | 27566939 | |
378 (in isoform 2) | Phosphorylation | - | 58.29 | 29514104 | |
403 | Phosphorylation | KKKWRKDSPWVKPSR HHHHHCCCCCCCCCH | 24.56 | 28066266 | |
452 | Phosphorylation | LELPSEGTLSPNHAG CCCCCCCCCCCCCCC | 21.73 | 22668510 | |
454 | Phosphorylation | LPSEGTLSPNHAGVS CCCCCCCCCCCCCCC | 24.40 | 29514104 | |
461 | Phosphorylation | SPNHAGVSNDTSSLE CCCCCCCCCCCCCCC | 28.24 | 22006019 | |
464 | Phosphorylation | HAGVSNDTSSLETER CCCCCCCCCCCCCCC | 25.19 | 24759943 | |
465 | Phosphorylation | AGVSNDTSSLETERG CCCCCCCCCCCCCCC | 35.47 | 21743459 | |
466 | Phosphorylation | GVSNDTSSLETERGF CCCCCCCCCCCCCCC | 32.11 | 21743459 | |
469 | Phosphorylation | NDTSSLETERGFEEL CCCCCCCCCCCCCCC | 35.95 | 21743459 | |
608 | Phosphorylation | IPRGDGGTPPIGTAA ECCCCCCCCCCCCCC | 31.27 | 25521595 | |
613 | Phosphorylation | GGTPPIGTAAPALPP CCCCCCCCCCCCCCC | 21.99 | 25619855 | |
635 | Phosphorylation | RADTSQPSARMRGHG CCCCCCCCHHHCCCC | 22.37 | - | |
798 | Phosphorylation | VQLGGCVYSKEEDGS HHCCCCEEECCCCCC | 20.36 | - | |
939 | Phosphorylation | LRNKEGDTAWDLTPE HCCCCCCCCCCCCCC | 40.27 | - | |
1044 | Phosphorylation | NCLCGQLSIRCWYDK CCEECCEEEEEEECC | 10.49 | 22942356 | |
1100 | Ubiquitination | LQLYRTAKMGWGVRA HHHHHHHCCCCCEEE | 37.01 | 22790023 | |
1161 | Phosphorylation | ARYYGNISRFINHLC CEEECCHHHHHHHHC | 25.74 | - | |
1199 | Phosphorylation | FSSRDIRTGEELGFD EECCCCCCCCCCCCC | 49.64 | - | |
1257 | Phosphorylation | ELLPDLSSLPPINT- HHCCCHHHCCCCCC- | 52.79 | - | |
1263 | Phosphorylation | SSLPPINT------- HHCCCCCC------- | 40.48 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
287 | S | Phosphorylation | Kinase | MTOR | Q9JLN9 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
239 | K | Methylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EHMT2_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...